CN1125117A

CN1125117A - Ointment for curing eczema

Info

Publication number: CN1125117A
Application number: CN 94119697
Authority: CN
Inventors: 王登科; 汪绍懿
Original assignee: HUOJU SCIENCE AND TECHNOLOGY DEVELOPMENT INDUSTRY Co KUNMING CITY
Current assignee: HUOJU SCIENCE AND TECHNOLOGY DEVELOPMENT INDUSTRY Co KUNMING CITY
Priority date: 1994-12-22
Filing date: 1994-12-22
Publication date: 1996-06-26
Anticipated expiration: 2014-12-22
Also published as: CN1061236C

Abstract

The ointment for external use to treat dermopathy is comprised of the following ingredients of (WT%) 2-15% of coptis root, 1-15% of flavescent sophora root, 1-10% of atractylodes root, 1-20% of dittary bark, 1-15% of secluded chamber, 1-20% of notoginseng root, 1-30% of smithsonite, 0.5-10% of zanthoxylum husk, 0.5-15% of borneol, 0.5-15% of licorice and 2-30% of excipient. Said ointment for external use has the functions of clearing away heat and removing dampness, promoting blood circulation and relieving swelling and dispelling wind and relieving itching, and mainly is used for treating eczema, etc..

Description

Eczema ointment

The present invention relates to the natural plant extracts is the dermopathic external used medicine of treatment of effective ingredient.

Chinese patent application CN1078396 (application number 93103020) discloses a kind of " medicine for treating dermatosis and manufacture method thereof ", it comprises Calomelas, sulfur, Realgar, Aerugo, dried Alumen, it is characterized in that: this medicine also comprises Lu Ganshi, Borneolum Syntheticum, dens, Gypsum Fibrosum powder, Mentholum, Carassius auratus frost, Semen Vignae Radiatae flour, hydroxytetracycline tablet, dexamethasone tablet, and use fluocinolone acetonide cream or halcinonidedcorten ointment or clotrimazole ointment double as blender, their share is as follows: Calomelas 12-20 gram, sulfur 5-10 gram, Realgar 5-10 gram, Aerugo 10-20 gram, dried Alumen 3-6 gram, Lu Ganshi 20-200 gram, Borneolum Syntheticum 5-10 gram, dens 30-300 gram, Gypsum Fibrosum powder 18-180 gram, Mentholum 5-10 gram, Carassius auratus frost 5-10 gram, Semen Vignae Radiatae flour 10-500 gram, hydroxytetracycline tablet 3-6 gram, dexamethasone tablet 2-4 gram, and fluocinolone acetonide cream or halcinonidedcorten ointment or clotrimazole ointment 1300-5000 gram.

Chinese patent application CN1021305 (application number 87102282) discloses a kind of " production method of eczema medicine ", it is characterized in that: a, the root that will contain the plant of three Saponins, stem, leaf and the root of plant that contains berberine are by 1: 9-1: in the time of 1 4-7 times, seethed with excitement 5-0 minute, when spissated amount is 0.5-1 times of drug weight, can be used as decoct uses, b, get concentrated solution 1 part (weight) and add water 10-20 doubly, heating bath can be treated the erythra of general, c, with the medicine after smashing to pieces, grind to form fine powder, promptly become powder, add bright boiled water insulation subsequently and soak, take to soak and use, d, ground powder and medicinal vaseline are pressed 3: 7-4: the mixed of 8 (weight ratios), the cream system of making stirs.

Chinese patent application CN1075652 (application number 93102292) discloses a kind of " Chinese medicine preparation of treatment dermatopathy and preparation method thereof ", it is characterized in that: this 100 weight portion Chinese medicine preparation is that Herba Portulacae, Aloe, Herba Mimosae Pudicae, Folium Artemisiae Argyi, Moschus and tablet vinegar are formed, its percentage by weight is Herba Portulacae 2-2.5, Aloe 2-2.2, Herba Mimosae Pudicae 0.25-0.5, Folium Artemisiae Argyi 0.1-0.225, all the other are tablet vinegar for Moschus moschiferous 0.001-0.005.

Purpose of the present invention aims to provide a kind of removing damp-heat, promoting blood circulation and detumescence, is used for the treatment of dermopathic external preparation.

Eczema ointment of the present invention is grouped into (percentage by weight) by following one-tenth: Rhizoma Coptidis 2-15%, Radix Sophorae Flavescentis 1-15%, Rhizoma Atractylodis 1-10%, Cortex Dictamni 1-20%, Rhizoma Paridis 1-15%, Radix Notoginseng 1-20%, Calamina 1-30%, Pericarpium Zanthoxyli 0.5-10%, Borneolum Syntheticum 0.5-15%, Radix Glycyrrhizae 0.5-15%, excipient 2-30% make pharmaceutically receivable external preparation.

Medicine of the present invention cures mainly because of the eczema due to the rheumatism pyretic toxicity, and affected part flushing, pruritus are oozed out diseases such as Jin Shui after scratching, has removing damp-heat, promoting blood circulation and detumescence, effect such as dispelling wind is antipruritic can be made into multiple exterior-applied formulations such as ointment, cream, ointment, ointment, wet unguentum.Through the materia medica test, this eczema ointment has no side effect to human body, and pathogen growth and breeding are had better inhibitory action.

Embodiment:

Get Rhizoma Coptidis 80g, Radix Sophorae Flavescentis 60g, Rhizoma Atractylodis 60g, Cortex Dictamni 100g, Rhizoma Paridis 100g, Pericarpium Zanthoxyli 30g, Radix Glycyrrhizae 80g breaks into coarse powder, adds five times of water logging bubbles one hour, boils one hour, filters, and repeatedly for several times, merges leach cooking liquid, is concentrated into the about qdx of crude drug, uses.

Get Calamina 30g, Radix Notoginseng 50g, Borneolum Syntheticum 30g beats powder respectively, and it is standby to cross 100 orders.

Heating adds excipient caustic potash in above-mentioned Chinese medicine concentrated solution, triethanolamine, ethanol, make its dissolving, in addition excipient stearic acid, glycerol, newborn wax, white oil etc. are heated to and slowly pour above-mentioned aqueous phase about 90 ℃ into, simultaneously continuous material controlling makes emulsifying, add Calamina, Radix Notoginseng, Borneolum Syntheticum fine powder again, mixing gets final product.

Can add an amount of essence or antiseptic.

Claims

1, a kind of eczema ointment, it is characterized in that being grouped into (percentage by weight): Rhizoma Coptidis 2-15%, Radix Sophorae Flavescentis 1-15% by following one-tenth, Rhizoma Atractylodis 1-10%, Cortex Dictamni 1-20%, Rhizoma Paridis 1-15%, Radix Notoginseng 1-20%, Calamina 1-30%, Pericarpium Zanthoxyli 0.5-10%, Borneolum Syntheticum 0.5-15%, Radix Glycyrrhizae 0.5-15%, excipient 2-30% make pharmaceutically receivable external preparation.